Evrysdi and Tremor - a phase IV clinical study of FDA data

Summary:

Tremor is reported as a side effect among people who take Evrysdi (risdiplam), especially for people who are female, 2-9 old, also take Famotidine, and have Spinal muscular atrophy.

The phase IV clinical study analyzes which people have Tremor when taking Evrysdi. It is created by eHealthMe based on reports of 2,321 people who have side effects when taking Evrysdi from the FDA, and is updated regularly.

What is Evrysdi?

Evrysdi has active ingredients of risdiplam. eHealthMe is studying from 2,323 Evrysdi users. Check the latest studies of Evrysdi.

What is Tremor?

Tremor (trembling or shaking movements in one or more parts of your body) is found to be associated with 2,645 drugs and 3,730 conditions by eHealthMe. Check the latest studies of Tremor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

2,321 people reported to have side effects when taking Evrysdi.
Among them, 13 people (0.56%) have Tremor.

Among these 13 people:

What is the gender of people who have Tremor when taking Evrysdi? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Tremor when taking Evrysdi? *

What are other drugs people take besides Evrysdi? *

Synagis: 1 person, 7.69%
Gabapentin: 1 person, 7.69%
Famotidine: 1 person, 7.69%

What are other side effects people have besides Tremor? *

Weakness: 4 people, 30.77%
Heart Rate Increased: 3 people, 23.08%
Blood Glucose Increased: 2 people, 15.38%
Sensory Disturbance (sense disturbance): 1 person, 7.69%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.69%
Cough: 1 person, 7.69%
Diarrhea: 1 person, 7.69%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
Facial Paresis (weakness in facial muscle movement): 1 person, 7.69%
Fatigue (feeling of tiredness): 1 person, 7.69%

What are the existing conditions these people have? *

Spinal Muscular Atrophy (wasting of spinal muscles): 10 people, 76.92%
Muscle Atrophy (a decrease in the mass of the muscle): 3 people, 23.08%
Indigestion: 1 person, 7.69%
High Blood Cholesterol: 1 person, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Evrysdi and have Tremor?

- Check whether Tremor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evrysdi:

Evrysdi (2,323 reports)

Tremor treatments and more:

Tremor (195,267 reports)

Browse all side effects of Evrysdi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tremor:

Tremor (2,645 drugs)

Browse all the conditions that are associated with Tremor:

Tremor (3,730 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on risdiplam (the active ingredients of Evrysdi) and Evrysdi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.